Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

The 2016-2019 ImmunoTOX assessment board report of collaborative management of immune-related adverse events, an observational clinical study.

Michot JM, Lappara A, Le Pavec J, Simonaggio A, Collins M, De Martin E, Danlos FX, Ammari S, Cauquil C, Ederhy S, Barreau E, Belkhir R, Berdelou A, Lazarovici J, Chanson P, Izzedine H, Seferian A, Le Pajolec C, Baldini C, Martin-Romano P, Mariette X, Robert C, Besse B, Hollebecque A, Varga A, Laghouati S, Mateus C, Voisin AL, Soria JC, Massard C, Marabelle A, Champiat S, Lambotte O.

Eur J Cancer. 2020 Mar 12;130:39-50. doi: 10.1016/j.ejca.2020.02.010. [Epub ahead of print]

PMID:
32172197
2.

Pregnancy after lung and heart-lung transplantation: a French multicentre retrospective study of 39 pregnancies.

Bry C, Hubert D, Reynaud-Gaubert M, Dromer C, Mal H, Roux A, Boussaud V, Claustre J, Le Pavec J, Murris-Espin M, Danner-Boucher I.

ERJ Open Res. 2019 Oct 30;5(4). pii: 00254-2018. doi: 10.1183/23120541.00254-2018. eCollection 2019 Oct.

3.

Impact of donor, recipient and matching on survival after high emergency lung transplantation in France.

Roussel A, Sage E, Massard G, Thomas PA, Castier Y, Fadel E, Le Pimpec-Barthes F, Maury JM, Jougon J, Lacoste P, Claustre J, Dahan M, Pirvu A, Tissot A, Thumerel M, Drevet G, Pricopi C, Le Pavec J, Mal H, D'Journo XB, Kessler R, Roux A, Dorent R, Thabut G, Mordant P; French Groups of Lung Transplantation.

Eur Respir J. 2019 Nov 7;54(5). pii: 1900096. doi: 10.1183/13993003.00096-2019. Print 2019 Nov.

PMID:
31601709
4.

Perspectives on Scedosporium species and Lomentospora prolificans in lung transplantation: Results of an international practice survey from ESCMID fungal infection study group and study group for infections in compromised hosts, and European Confederation of Medical Mycology.

Rammaert B, Puyade M, Cornely OA, Seidel D, Grossi P, Husain S, Picard C, Lass-Flörl C, Manuel O, Le Pavec J, Lortholary O; SCEDO-LUNG collaborative group.

Transpl Infect Dis. 2019 Oct;21(5):e13141. doi: 10.1111/tid.13141. Epub 2019 Jul 22.

PMID:
31283872
5.

Evaluation of Readministration of Immune Checkpoint Inhibitors After Immune-Related Adverse Events in Patients With Cancer.

Simonaggio A, Michot JM, Voisin AL, Le Pavec J, Collins M, Lallart A, Cengizalp G, Vozy A, Laparra A, Varga A, Hollebecque A, Champiat S, Marabelle A, Massard C, Lambotte O.

JAMA Oncol. 2019 Jun 6. doi: 10.1001/jamaoncol.2019.1022. [Epub ahead of print]

PMID:
31169866
6.

Alveolar Septal Widening as an "Alert" Signal to Look Into Lung Antibody-mediated Rejection: A Multicenter Pilot Study.

Calabrese F, Hirschi S, Neil D, Montero-Fernandez A, Timens W, Verbeken E, Chenard MP, Ivanovic M, Le Pavec J, Pena T, Dorfmüller P, Roux A, Rice A, Perissinotto E, Lunardi F, Levine DJ, Cozzi E, Goddard M.

Transplantation. 2019 Nov;103(11):2440-2447. doi: 10.1097/TP.0000000000002688.

PMID:
30830043
7.

Heart-lung transplantation: current indications, prognosis and specific considerations.

Le Pavec J, Hascoët S, Fadel E.

J Thorac Dis. 2018 Oct;10(10):5946-5952. doi: 10.21037/jtd.2018.09.115. Review.

8.

[COLT: Ten years of research in lung transplantation, results and perspectives].

Tissot A, Foureau A, Brosseau C, Danger R, Roux A, Bernasconi E, Gomez C, Durand M, Picard BR, Le Pavec J, Claustre J, Lacoste P, Benmerad M, Pain M, Siroux V, Royer PJ, Mordant P, Reynaud-Gaubert M, Kessler R, Brugière O, Mornex JF, Dromer C, Dahan M, Knoop C, Boussaud V, Koutsokera A, Botturi-Cavaillès K, Durand E, Loy J, Nicod L, Pison C, Brouard S, Blanc FX, Magnan A; consortium COLT.

Rev Mal Respir. 2018 Sep;35(7):699-705. doi: 10.1016/j.rmr.2018.06.007. Epub 2018 Aug 9. French. No abstract available.

PMID:
30100530
9.

Role of C1q-binding anti-HLA antibodies as a predictor of lung allograft outcome.

Brugière O, Roux A, Le Pavec J, Sroussi D, Parquin F, Pradère P, Dupin C, Bunel V, Mourin G, Jebrak G, Dauriat G, Castier Y, Mordant P, Lortat-Jacob B, Jean-Baptiste S, Mal H, Suberbielle C, Gautreau C, Caillat-Zucman S, Cazes A, Thabut G, Taupin JL.

Eur Respir J. 2018 Aug 23;52(2). pii: 1701898. doi: 10.1183/13993003.01898-2017. Print 2018 Aug.

10.

Clinical phenotypes and survival of pre-capillary pulmonary hypertension in systemic sclerosis.

Launay D, Montani D, Hassoun PM, Cottin V, Le Pavec J, Clerson P, Sitbon O, Jaïs X, Savale L, Weatherald J, Sobanski V, Mathai SC, Shafiq M, Cordier JF, Hachulla E, Simonneau G, Humbert M.

PLoS One. 2018 May 15;13(5):e0197112. doi: 10.1371/journal.pone.0197112. eCollection 2018.

11.

Natural History over 8 Years of Pulmonary Vascular Disease in a Patient Carrying Biallelic EIF2AK4 Mutations.

Montani D, Dorfmüller P, Girerd B, Le Pavec J, Fadel E, Simonneau G, Sitbon O, Humbert M.

Am J Respir Crit Care Med. 2018 Aug 15;198(4):537-541. doi: 10.1164/rccm.201802-0317LE. No abstract available.

PMID:
29702008
12.

Detection of immune-related adverse events by medical imaging in patients treated with anti-programmed cell death 1.

Mekki A, Dercle L, Lichtenstein P, Marabelle A, Michot JM, Lambotte O, Le Pavec J, De Martin E, Balleyguier C, Champiat S, Ammari S.

Eur J Cancer. 2018 Jun;96:91-104. doi: 10.1016/j.ejca.2018.03.006. Epub 2018 Apr 23.

PMID:
29698933
13.

Lung transplantation for scleroderma lung disease: An international, multicenter, observational cohort study.

Pradère P, Tudorache I, Magnusson J, Savale L, Brugiere O, Douvry B, Reynaud-Gaubert M, Claustre J, Borgne AL, Holm AM, Schultz HH, Knoop C, Godinas L, Fisher AJ, Hirschi S, Gottlieb J, Le Pavec J; Working Group on Heart/Lung Transplantation in Systemic Sclerosis.

J Heart Lung Transplant. 2018 Jul;37(7):903-911. doi: 10.1016/j.healun.2018.03.003. Epub 2018 Mar 15.

PMID:
29628135
14.

Central versus peripheral cannulation of extracorporeal membrane oxygenation support during double lung transplant for pulmonary hypertension.

Glorion M, Mercier O, Mitilian D, De Lemos A, Lamrani L, Feuillet S, Pradere P, Le Pavec J, Lehouerou D, Stephan F, Savale L, Fabre D, Mussot S, Fadel E.

Eur J Cardiothorac Surg. 2018 Aug 1;54(2):341-347. doi: 10.1093/ejcts/ezy089.

PMID:
29528384
15.

Pulmonary nodules and immunotherapy: disease progression or toxicity of anti-PD1/anti-PDL1 checkpoint inhibitors?

Pradère P, Boutros C, Scoazec JY, Dorfmüller P, Leroy-Ladurie F, Boulate D, Le Pavec J, Robert C.

Eur J Cancer. 2018 Apr;93:144-146. doi: 10.1016/j.ejca.2017.12.013. Epub 2018 Feb 3. No abstract available.

PMID:
29402507
16.

Immunotherapy and pulmonary toxicities: can concomitant immune-checkpoint inhibitors with radiotherapy increase the risk of radiation pneumonitis?

Louvel G, Bahleda R, Ammari S, Le Péchoux C, Levy A, Massard C, Le Pavec J, Champiat S, Deutsch E.

Eur Respir J. 2018 Jan 4;51(1). pii: 1701737. doi: 10.1183/13993003.01737-2017. Print 2018 Jan. No abstract available.

17.

Impact of High-Priority Allocation on Lung and Heart-Lung Transplantation for Pulmonary Hypertension.

Savale L, Le Pavec J, Mercier O, Mussot S, Jaïs X, Fabre D, O'Connell C, Montani D, Stephan F, Sitbon O, Simonneau G, Dartevelle P, Humbert M, Fadel E.

Ann Thorac Surg. 2017 Aug;104(2):404-411. doi: 10.1016/j.athoracsur.2017.02.034. Epub 2017 May 18.

PMID:
28527964
18.

Allergic broncho-pulmonary aspergillosis following treatment with an anti-programmed cell death protein 1 monoclonal antibody therapy.

Pradere P, Michot JM, Champiat S, Danlos FX, Marabelle A, Lambotte O, Albiges L, Le Pavec J.

Eur J Cancer. 2017 Apr;75:308-309. doi: 10.1016/j.ejca.2016.12.027. Epub 2017 Mar 1. No abstract available.

PMID:
28259013
19.

Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno-occlusive disease: a population-based study.

Montani D, Girerd B, Jaïs X, Levy M, Amar D, Savale L, Dorfmüller P, Seferian A, Lau EM, Eyries M, Le Pavec J, Parent F, Bonnet D, Soubrier F, Fadel E, Sitbon O, Simonneau G, Humbert M.

Lancet Respir Med. 2017 Feb;5(2):125-134. doi: 10.1016/S2213-2600(16)30438-6. Epub 2017 Jan 11.

PMID:
28087362
20.

De-novo donor-specific anti-HLA antibodies 30 days after lung transplantation are associated with a worse outcome.

Le Pavec J, Suberbielle C, Lamrani L, Feuillet S, Savale L, Dorfmüller P, Stephan F, Mussot S, Mercier O, Fadel E.

J Heart Lung Transplant. 2016 Sep;35(9):1067-77. doi: 10.1016/j.healun.2016.05.020. Epub 2016 May 31.

PMID:
27373824
21.

[Consortium for detection and management of lung damage induced by bleomycin].

Biya J, Stoclin A, Dury S, Le Pavec J, Mir O, Lazarovici J, Fermé C, Annereau M, Ekpe K, Massard C, Michot JM.

Bull Cancer. 2016 Jul-Aug;103(7-8):651-61. doi: 10.1016/j.bulcan.2016.04.005. Epub 2016 May 27. Review. French.

PMID:
27241272
22.

Life-threatening Hughes-Stovin syndrome: The Yin and Yang of anticoagulation therapy.

Villié P, Noël N, Ackermann F, Rivoisy C, Le Pavec J, Savale L, Goujard C, Rocher L, Lambotte O.

Joint Bone Spine. 2016 Jul;83(4):459-60. doi: 10.1016/j.jbspin.2015.05.006. Epub 2015 Nov 19. Review. No abstract available.

PMID:
26777106
23.

Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper.

Champiat S, Lambotte O, Barreau E, Belkhir R, Berdelou A, Carbonnel F, Cauquil C, Chanson P, Collins M, Durrbach A, Ederhy S, Feuillet S, François H, Lazarovici J, Le Pavec J, De Martin E, Mateus C, Michot JM, Samuel D, Soria JC, Robert C, Eggermont A, Marabelle A.

Ann Oncol. 2016 Apr;27(4):559-74. doi: 10.1093/annonc/mdv623. Epub 2015 Dec 28. Review.

24.

Occupational exposure to organic solvents: a risk factor for pulmonary veno-occlusive disease.

Montani D, Lau EM, Descatha A, Jaïs X, Savale L, Andujar P, Bensefa-Colas L, Girerd B, Zendah I, Le Pavec J, Seferian A, Perros F, Dorfmüller P, Fadel E, Soubrier F, Sitbon O, Simonneau G, Humbert M.

Eur Respir J. 2015 Dec;46(6):1721-31. doi: 10.1183/13993003.00814-2015. Epub 2015 Nov 5.

25.

Lymphoproliferative Disorders after Lung Transplantation: Clinicopathological Characterization of 16 Cases with Identification of Very-Late-Onset Forms.

Thomas de Montpréville V, Le Pavec J, Le Roy Ladurie F, Crutu A, Mussot S, Fabre D, Mercier O, Dorfmuller P, Ghigna MR, Fadel É.

Respiration. 2015;90(6):451-9. doi: 10.1159/000441064. Epub 2015 Oct 28.

26.

Severe hematologic complications after lung transplantation in patients with telomerase complex mutations.

Borie R, Kannengiesser C, Hirschi S, Le Pavec J, Mal H, Bergot E, Jouneau S, Naccache JM, Revy P, Boutboul D, Peffault de la Tour R, Wemeau-Stervinou L, Philit F, Cordier JF, Thabut G, Crestani B, Cottin V; Groupe d’Etudes et de Recherche sur les Maladies “Orphelines” Pulmonaires (GERM“O”P).

J Heart Lung Transplant. 2015 Apr;34(4):538-46. doi: 10.1016/j.healun.2014.11.010. Epub 2014 Nov 13.

27.

Systematic analysis of blood cell transcriptome in end-stage chronic respiratory diseases.

Chesné J, Danger R, Botturi K, Reynaud-Gaubert M, Mussot S, Stern M, Danner-Boucher I, Mornex JF, Pison C, Dromer C, Kessler R, Dahan M, Brugière O, Le Pavec J, Perros F, Humbert M, Gomez C, Brouard S, Magnan A; COLT Consortium.

PLoS One. 2014 Oct 20;9(10):e109291. doi: 10.1371/journal.pone.0109291. eCollection 2014.

28.

Lung and heart-lung transplantation for systemic sclerosis patients. A monocentric experience of 13 patients, review of the literature and position paper of a multidisciplinary Working Group.

Launay D, Savale L, Berezne A, Le Pavec J, Hachulla E, Mouthon L, Sitbon O, Lambert B, Gaudric M, Jais X, Stephan F, Hatron PY, Lamblin N, Vignaux O, Cottin V, Farge D, Wallaert B, Guillevin L, Simonneau G, Mercier O, Fadel E, Dartevelle P, Humbert M, Mussot S; Working Group on Heart/Lung transplantation in systemic sclerosis of the French Network on Pulmonary Hypertension.

Presse Med. 2014 Oct;43(10 Pt 2):e345-63. doi: 10.1016/j.lpm.2014.01.020. Epub 2014 Jul 11. Review.

PMID:
25027464
29.

Efficacy, safety and pharmacokinetics of bosentan in portopulmonary hypertension.

Savale L, Magnier R, Le Pavec J, Jaïs X, Montani D, O'Callaghan DS, Humbert M, Dingemanse J, Simonneau G, Sitbon O.

Eur Respir J. 2013 Jan;41(1):96-103. doi: 10.1183/09031936.00117511. Epub 2012 May 31.

30.

Pulmonary Langerhans cell histiocytosis-associated pulmonary hypertension: clinical characteristics and impact of pulmonary arterial hypertension therapies.

Le Pavec J, Lorillon G, Jaïs X, Tcherakian C, Feuillet S, Dorfmüller P, Simonneau G, Humbert M, Tazi A.

Chest. 2012 Nov;142(5):1150-1157. doi: 10.1378/chest.11-2490.

PMID:
22459770
31.

Systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease: impact of pulmonary arterial hypertension therapies.

Le Pavec J, Girgis RE, Lechtzin N, Mathai SC, Launay D, Hummers LK, Zaiman A, Sitbon O, Simonneau G, Humbert M, Hassoun PM.

Arthritis Rheum. 2011 Aug;63(8):2456-64. doi: 10.1002/art.30423.

32.

[Systemic sclerosis associated pulmonary arterial hypertension: the pitfalls].

Hachulla E, Launay D, Le Pavec J, Mouthon L, Guillevin L, de Groote P.

Presse Med. 2011 Apr;40 Suppl 1:1S46-53. doi: 10.1016/S0755-4982(11)70007-0. French.

PMID:
21536180
33.

Clinical characteristics and survival in systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease.

Launay D, Humbert M, Berezne A, Cottin V, Allanore Y, Couderc LJ, Bletry O, Yaici A, Hatron PY, Mouthon L, Le Pavec J, Clerson P, Hachulla E.

Chest. 2011 Oct;140(4):1016-1024. doi: 10.1378/chest.10-2473. Epub 2011 Apr 7.

PMID:
21474572
34.

Outcomes of hospitalisation for right heart failure in pulmonary arterial hypertension.

Campo A, Mathai SC, Le Pavec J, Zaiman AL, Hummers LK, Boyce D, Housten T, Lechtzin N, Chami H, Girgis RE, Hassoun PM.

Eur Respir J. 2011 Aug;38(2):359-67. doi: 10.1183/09031936.00148310. Epub 2011 Feb 10.

35.

Current management approaches to portopulmonary hypertension.

Savale L, O'Callaghan DS, Magnier R, Le Pavec J, Hervé P, Jaïs X, Seferian A, Humbert M, Simonneau G, Sitbon O.

Int J Clin Pract Suppl. 2011 Jan;(169):11-8. doi: 10.1111/j.1742-1241.2010.02600.x. Review.

PMID:
21176011
36.

Hemodynamic predictors of survival in scleroderma-related pulmonary arterial hypertension.

Campo A, Mathai SC, Le Pavec J, Zaiman AL, Hummers LK, Boyce D, Housten T, Champion HC, Lechtzin N, Wigley FM, Girgis RE, Hassoun PM.

Am J Respir Crit Care Med. 2010 Jul 15;182(2):252-60. doi: 10.1164/rccm.200912-1820OC. Epub 2010 Mar 25.

37.

Systemic sclerosis-associated pulmonary arterial hypertension.

Le Pavec J, Humbert M, Mouthon L, Hassoun PM.

Am J Respir Crit Care Med. 2010 Jun 15;181(12):1285-93. doi: 10.1164/rccm.200909-1331PP. Epub 2010 Mar 1. Review.

38.

Scleroderma lung disease.

Le Pavec J, Launay D, Mathai SC, Hassoun PM, Humbert M.

Clin Rev Allergy Immunol. 2011 Apr;40(2):104-16. doi: 10.1007/s12016-009-8194-2.

PMID:
20063208
39.

Long-term outcome of systemic sclerosis-associated pulmonary arterial hypertension treated with bosentan as first-line monotherapy followed or not by the addition of prostanoids or sildenafil.

Launay D, Sitbon O, Le Pavec J, Savale L, Tchérakian C, Yaïci A, Achouh L, Parent F, Jais X, Simonneau G, Humbert M.

Rheumatology (Oxford). 2010 Mar;49(3):490-500. doi: 10.1093/rheumatology/kep398. Epub 2009 Dec 16.

PMID:
20015974
40.

HIV-associated pulmonary arterial hypertension: survival and prognostic factors in the modern therapeutic era.

Degano B, Guillaume M, Savale L, Montani D, Jaïs X, Yaici A, Le Pavec J, Humbert M, Simonneau G, Sitbon O.

AIDS. 2010 Jan 2;24(1):67-75. doi: 10.1097/QAD.0b013e328331c65e.

PMID:
19770696
41.

Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome.

Cottin V, Le Pavec J, Prévot G, Mal H, Humbert M, Simonneau G, Cordier JF; GERM"O"P.

Eur Respir J. 2010 Jan;35(1):105-11. doi: 10.1183/09031936.00038709. Epub 2009 Jul 30.

42.

Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension.

Mathai SC, Bueso M, Hummers LK, Boyce D, Lechtzin N, Le Pavec J, Campo A, Champion HC, Housten T, Forfia PR, Zaiman AL, Wigley FM, Girgis RE, Hassoun PM.

Eur Respir J. 2010 Jan;35(1):95-104. doi: 10.1183/09031936.00074309. Epub 2009 Jul 30.

43.

Cirrhosis ameliorates monocrotaline-induced pulmonary hypertension in rats.

Le Pavec J, Perros F, Eddahibi S, Decante B, Dorfmuller P, Sitbon O, Lebrec D, Humbert M, Mazmanian M, Herve P.

Eur Respir J. 2009 Sep;34(3):731-9. doi: 10.1183/09031936.00006508. Epub 2009 Mar 26.

44.

[Pulmonary arterial hypertension associated with common diseases: connective-tissue diseases, HIV infection and portal hypertension].

Sitbon O, Jaïs X, Le Pavec J, Degano B, Humbert M, Simonneau G.

Rev Prat. 2008 Nov 30;58(18):2011-8. Review. French.

PMID:
19143272
45.

Long-term effects of bosentan in patients with HIV-associated pulmonary arterial hypertension.

Degano B, Yaïci A, Le Pavec J, Savale L, Jaïs X, Camara B, Humbert M, Simonneau G, Sitbon O.

Eur Respir J. 2009 Jan;33(1):92-8. doi: 10.1183/09031936.00094808. Epub 2008 Sep 17.

46.

Pulmonary veno-occlusive disease: clinical, functional, radiologic, and hemodynamic characteristics and outcome of 24 cases confirmed by histology.

Montani D, Achouh L, Dorfmüller P, Le Pavec J, Sztrymf B, Tchérakian C, Rabiller A, Haque R, Sitbon O, Jaïs X, Dartevelle P, Maître S, Capron F, Musset D, Simonneau G, Humbert M.

Medicine (Baltimore). 2008 Jul;87(4):220-33. doi: 10.1097/MD.0b013e31818193bb.

47.

Portopulmonary hypertension: survival and prognostic factors.

Le Pavec J, Souza R, Herve P, Lebrec D, Savale L, Tcherakian C, Jaïs X, Yaïci A, Humbert M, Simonneau G, Sitbon O.

Am J Respir Crit Care Med. 2008 Sep 15;178(6):637-43. doi: 10.1164/rccm.200804-613OC. Epub 2008 Jul 10.

PMID:
18617641
48.

Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension.

Perros F, Montani D, Dorfmüller P, Durand-Gasselin I, Tcherakian C, Le Pavec J, Mazmanian M, Fadel E, Mussot S, Mercier O, Hervé P, Emilie D, Eddahibi S, Simonneau G, Souza R, Humbert M.

Am J Respir Crit Care Med. 2008 Jul 1;178(1):81-8. doi: 10.1164/rccm.200707-1037OC. Epub 2008 Apr 17.

PMID:
18420966
49.

Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases.

Jais X, Launay D, Yaici A, Le Pavec J, Tchérakian C, Sitbon O, Simonneau G, Humbert M.

Arthritis Rheum. 2008 Feb;58(2):521-31. doi: 10.1002/art.23303.

50.

Pulmonary hypertension associated with myeloproliferative disorders: a retrospective study of ten cases.

Guilpain P, Montani D, Damaj G, Achouh L, Lefrère F, Le Pavec J, Marfaing-Koka A, Dartevelle P, Simonneau G, Humbert M, Hermine O.

Respiration. 2008;76(3):295-302. Epub 2007 Dec 21.

PMID:
18160817

Supplemental Content

Loading ...
Support Center